近日，国家知识产权出版社发布《金融科技行业2025年专利分析白皮书》与《医疗健康行业2025年专利 分析白皮书》(以下简称"白皮书")，揭示全球产业技术竞争的新格局。白皮书显示，2019年至2025年 间，中国企业在两大战略性行业的创新主导地位愈发巩固。其中，中国平安集团凭借持续且庞大的创新 产出，在金融科技与医疗健康两大行业的全球专利人榜单中再度双双位列第一，并在多项核心技术与关 键应用场景中占据领先地位。 双榜首引领：专利规模构筑创新护城河 平安集团的创新布局呈现出"核心技术聚焦+全场景覆盖"的鲜明特征，人工智能(AI)与大数据是驱动战 略的核心技术引擎。 在金融科技专利布局中，平安集团的专利覆盖广度与规模领先全行业，在人工智能、区块链、大数据三 大技术领域的专利数量均位列第一，且相关技术已深度融入业务肌理。例如，在智能客服与保险理赔两 大场景中，人工智能成效已然显现：平安2025年前三季度报告显示，依托AI与大数据的"保单复效难度 评分模型"及智能派工体系，推动保单复效率提升23%。 表1 金融科技行业全球专利权人TOP 10 在医疗健康领域，平安集团的领先优势同样显著，同期累计专利量达到5704件，位 ...

随着人口结构变化、疾病谱系变迁以及民众对健康品质需求的不断提升，单纯以疾病治疗为中心的医疗 模式已不能满足多元化的健康需求。社会办医作为公立医疗服务体系的重要补充，在这场变革中扮演着 愈发关键的角色。其中，由保险资本主导的医疗集团，因其独特的资源禀赋与商业模式，被视为重塑产 业格局的重要变量。 北大医疗作为这一领域的先行者与代表性机构，具有双重基因：一是源自北京大学医学部逾百年的深厚 学术底蕴、严谨医风与顶尖人才体系，这是其医疗品质的压舱石；二是来自中国平安集团的综合金融资 源、科技创新能力与庞大客户生态，这是其模式创新的推进器。两种不同的基因如何真正融合？险资办 医如何平衡医疗本质与市场逻辑？在医疗健康产业变革的十字路口，北大医疗如何走出一条可持续的创 新之路？针对上述问题，近日，《金融时报》记者对北大医疗董事长、平安健康险董事长兼首席执行官 朱友刚进行了专访。 《金融时报》记者：北大医疗所实践的"保险+医疗"模式，最根本的优势与核心的挑战是什么？在实践 中，北大医疗如何用好"北大底蕴"与"平安特色"？ 朱友刚：首先谈优势。险资办医，尤其是背靠大型综合金融集团办医，核心优势在于两个方面。一是构 建"支付+服 ...

Core Insights - The insurance industry is experiencing a transformation driven by the influx of high-end talent from various sectors, responding to changing customer demands for comprehensive solutions rather than simple insurance policies [1][2][4] - Companies are implementing specialized training programs and recruitment initiatives to attract and retain professional talent, enhancing their service offerings and operational capabilities [2][3] Group 1: Talent Transformation - Chen Jitao, a former private banking executive, transitioned to a role at Ping An Life, seeking a platform that allows for greater personal agency and long-term commitment [1] - High-end professionals from diverse backgrounds, including finance, law, and healthcare, are increasingly entering the insurance sector, bringing valuable resources and expertise [1][2] - Ping An Life's "High Talent Manager Training Program" and similar initiatives from other leading insurers aim to provide structured training and resources to enhance the capabilities of new recruits [2] Group 2: Industry Dynamics - The competition among insurance companies has intensified, leading to a focus on professional development and the establishment of new management systems to support agents [3][4] - The entry of skilled professionals is reshaping the client relationship dynamics, with agents now expected to provide comprehensive financial planning and solutions [4] - Despite the positive momentum, challenges remain, including the integration of new talent with the existing large pool of agents and the pressure to balance long-term strategies with short-term performance metrics [5][6] Group 3: Market Challenges - The insurance industry faces a significant challenge in bridging the gap between newly recruited professional agents and the existing large number of traditional agents [5] - There is a tension between the need for long-term value creation and the pressure for immediate business performance, which complicates strategic decision-making [6] - Changing societal perceptions of insurance sales remains a hurdle, as many still hold outdated views of the profession [6]

随着人口结构变化、疾病谱系变迁以及民众对健康品质需求的不断提升，单纯以疾病治疗为中心的 医疗模式已不能满足多元化的健康需求。社会办医作为公立医疗服务体系的重要补充，在这场变革中扮 演着愈发关键的角色。其中，由保险资本主导的医疗集团，因其独特的资源禀赋与商业模式，被视为重 塑产业格局的重要变量。 北大医疗作为这一领域的先行者与代表性机构，具有双重基因：一是源自北京大学医学部逾百年的 深厚学术底蕴、严谨医风与顶尖人才体系，这是其医疗品质的压舱石；二是来自中国平安集团的综合金 融资源、科技创新能力与庞大客户生态，这是其模式创新的推进器。两种不同的基因如何真正融合？险 资办医如何平衡医疗本质与市场逻辑？在医疗健康产业变革的十字路口，北大医疗如何走出一条可持续 的创新之路？针对上述问题，近日，《金融时报》记者对北大医疗董事长、平安健康险董事长兼首席执 行官朱友刚进行了专访。 《金融时报》记者：北大医疗所实践的"保险+医疗"模式，最根本的优势与核心的挑战是什么？在 实践中，北大医疗如何用好"北大底蕴"与"平安特色"？ 朱友刚：首先谈优势。险资办医，尤其是背靠大型综合金融集团办医，核心优势在于两个方面。一 是构建"支付+服 ...

- The report introduces a quantitative model framework for market trend analysis, focusing on five asset style stages: external growth, quality growth, quality dividend, value dividend, and bankruptcy value. The model evaluates assets based on their intrinsic attributes and prioritizes them using the sequence of g > ROE > D, analyzing whether there are "good assets" and whether they are "expensive" [5][8][9] - The model incorporates key factors such as expected growth (gf), actual growth (g), profitability (ROE), high dividend (D), and bankruptcy value (B/P). Each factor is associated with specific market phases, e.g., expected growth is relevant across all phases, while profitability is emphasized during maturity phases [9][12] - The quantitative model has demonstrated strong historical performance, achieving an annualized return of 27.67% since 2009. It has shown consistent excess returns in most years, particularly post-2017, with limited effectiveness in years like 2011, 2012, and 2016 [19][22] - The model's backtesting results for specific years include notable excess returns, such as 51% in 2009, 36% in 2013, and 62% in 2022. However, it also recorded underperformance in years like 2011 (-11%) and 2014 (-4%) [22] - The report details six specific strategies derived from the model, each focusing on different factors: - **Expected Growth Strategy**: Selects industries with the highest analyst-forecasted growth rates. Recent recommendations include sectors like automotive sales, lithium equipment, and tungsten [38][39] - **Actual Growth Strategy**: Focuses on industries with the highest unexpected growth (△g). Current recommendations include photovoltaic equipment, insurance, and coal chemical sectors [40][41] - **Profitability Strategy**: Targets high-ROE industries with low valuations under the PB-ROE framework. Recommended sectors include copper, liquor, and non-dairy beverages [43][44] - **Quality Dividend Strategy**: Utilizes a DP+ROE scoring system to identify industries. Current recommendations include forestry, lithium equipment, and fiberglass [46][47] - **Value Dividend Strategy**: Employs a DP+BP scoring system. Recommended sectors include security, daily chemicals, and buses [49][50] - **Bankruptcy Value Strategy**: Focuses on industries with the lowest PB+SIZE scores. Current recommendations include automotive sales, ceramics, and cotton textiles [53][54]

二、中国平安财产保险股份有限公司应按照有关规定及时办理变更及许可证换领事宜。 一、同意中国平安财产保险股份有限公司成安支公司将营业场所变更为：河北省邯郸市成安县青云大街 西侧、朱雀路北侧业玖大厦B座12层1201、1212。 2026年1月27日，邯郸金融监管分局发布批复称，《中国平安财产保险股份有限公司河北分公司关于变 更平安财险成安支公司营业场所的请示》(平保产冀分发〔2025〕165号)收悉。经审核，现批复如下： ...

智能预警联动救援,小保单托举大民生 御享金越年金的核心竞争力源于其背后的投资体系,产品依托平安人寿专为分红险打造的"稳赢宝"账户, 执行"三仓"配置策略:长期战略仓锁定穿越周期的底层收益,中期情境仓灵活应对市场风格切换,短期战术 仓捕捉波段机会。这一机制直接体现在业绩上,中国平安2025年三季度财报显示,其保险资金投资组合实 现非年化综合投资收益率5.4%。凭借优异的综合投资实力,平安人寿在南方周末"金标杆-寿险投资能力 榜"中位列万亿级险企之首。产品设计上,御享金越年金在交费期满一定年度后,现金价值持续增长,保单 持有人还可参与分配分红业务70%以上的可分配盈余,红利亦能转入万能账户实现二次增值。 日前,"完善服务体系 赋能科技生活"2025第七届上海普惠金融论坛在中国金融信息中心举行。会议聚焦 普惠金融治理体系完善与服务质效提升,探讨金融机构如何通过数字化转型破解融资难题、赋能科技产 业。在此背景下,平安人寿推出的御享金越年金凭借其稳健的分红机制与综合服务能力,备受关注。该产 品精准响应上海金融监管局关于2030年实现普惠金融服务能力跃升的规划,以供给侧改革为切入点,为客 户提供了穿越经济周期的财富管理方 ...

华宝港股通恒生中国(香港上市)30ETF（520560）现任基金经理为张放、蒋俊阳。张放自2025年9月24日 管理（或拟管理）该基金，任职期内收益-7.27%；蒋俊阳自2025年9月24日管理（或拟管理）该基金， 任职期内收益-7.27%。 来源：新浪基金∞工作室 数据显示，2月3日，华宝港股通恒生中国(香港上市)30ETF(520560)遭净赎回369.86万元，位居当日跨境 ETF净流出排名40/212。最新规模7.55亿元，前一日规模7.66亿元，当日资金净流出额占前一日规模的 比例为0.48%。 近5日，华宝港股通恒生中国(香港上市)30ETF(520560)遭净赎回3543.12万元，位居跨境ETF净流出排名 第25/212。近10日，华宝港股通恒生中国(香港上市)30ETF(520560)遭净赎回4572.63万元，位居跨境ETF 净流出排名第31/212。近20日，华宝港股通恒生中国(香港上市)30ETF(520560)遭净赎回6359.44万元， 位居跨境ETF净流出排名第40/212。 华宝港股通恒生中国(香港上市)30ETF（520560）成立于2025年9月24日，基金全称为华宝港股通 ...

2026年01月31日 证券研究报告|行业研究|行业点评 非银金融 非银行业周报 (2026年第四期) 2025 券商业绩整体向好，关注券商估值修复 市场表现: 本期（2026.1.26-2026.1.30）非银(申万)指数+1.04%、行业排 7/31,券商Ⅱ指 数-0.69%,保险II指数+5.50%; 上证综指-0.44%，深证成指-1.62%，创业板指-0.09%。 个股涨跌幅排名前五位：中国人寿（+8.73%）、中国太保（+8.48%）、新华保险 (+8.40%）、华鑫股份（+4.53%）、中国平安（+4.46%）; 个股涨跌幅排名后五位: 拉卡拉（-9.93%）、越秀资本（-8.00%）、浙江东方（- 6.37%）、华金资本（-6.18%）、海南华铁（-6.14%）。 (注：去除 ST 及退市股票) 核心观点: 证券: 市场层面,本周,证券板块下跌 0.69%,跑输沪深 300 指数 0.77pct,跑输上证综 指数 0.25pct。当前券商板块 PB 估值为 1.36 倍。 本周,券商密集发布业绩快报及预增报告,截至１月 30日,已有中信证券为代表 的四家上市券商披露业绩快报,另有国泰海通、国联 ...

Core Viewpoint - The article highlights the selection of 263 stocks by brokerages as "golden stocks," with a focus on balancing growth and stability amid macroeconomic uncertainties. The selected stocks are categorized into two main themes: embracing the AI-driven technology revolution and investing in value sectors benefiting from cyclical recovery. Group 1: Growth-Focused Stocks - The "offensive" aspect of the stock selection emphasizes a comprehensive layout in the AI industry, covering everything from infrastructure to application and cloud services, directly addressing the surging global demand for AI computing power and domestic alternatives [1][2] - Key stocks include Alibaba, which is expected to see a 32% revenue growth in its cloud business due to AI demand, and Tencent, which is leveraging AI in social and gaming sectors to enhance user engagement and monetization [3][9] Group 2: Stability-Focused Stocks - The "defensive" aspect is characterized by investments in companies with strong cash flows, policy benefits, and unique brand advantages. China Ping An is highlighted for its high dividend yield and improving fundamentals, while Kweichow Moutai benefits from its brand strength and channel reforms [2][5][18] - Other stable stocks include China Duty Free, which is expected to benefit from ongoing policy advantages in Hainan, and Foster, which is expanding its electronic materials business alongside its core photovoltaic operations [2][16][14] Group 3: Individual Stock Insights - **Alibaba**: Expected net profit of 1,045.52 million yuan in 2026, with a growing user base for AI products [3] - **Haiguang Information**: Revenue of 9.49 billion yuan in the first three quarters of 2025, with a year-on-year growth of 54.65% [4] - **China Ping An**: Projected net profit of 157.55 billion yuan in 2026, with a PE ratio of 7.59 [5] - **Wanhua Chemical**: Anticipated net profit of 16.36 billion yuan in 2026, with a PE ratio of 15.37 [7][8] - **Tencent**: Monthly active users of WeChat at 1.414 billion, with AI-related capital expenditures rising to 40% [10] - **Zijin Mining**: Expected net profit of 45.70 billion yuan in the first three quarters of 2025, with significant gold resource reserves [12][13] - **Foster**: Projected net profit growth of 49.98% in 2026, with over 50% market share in photovoltaic films [15] - **China Duty Free**: Expected net profit growth of 27.10% in 2026, benefiting from policy advantages [16][17] - **Kweichow Moutai**: Net profit of 66.90 billion yuan in the first three quarters of 2025, with a gross margin of 91.29% [18]